Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation
E AyalaS Goldstein

Abstract

Despite significant advances in prevention and therapy, cytomegalovirus (CMV) infection continues to be an important cause of morbidity and mortality in the hematopoietic stem cell transplant (HSCT) recipient. The standard drug for pre-emptive therapy is intravenous ganciclovir (GCV). Valganciclovir (VGC), the oral pro-drug of GCV, has excellent bioavailability and is ideal for oral therapy. Since March 2002, VGC was adopted in our center for outpatient pre-emptive therapy in all patients undergoing allogeneic HSCT. Fifty-two allogeneic HSCT recipients were followed weekly via Digene hybrid capture assay. Patients with a positive assay were treated with VGC 900 mg p.o. b.i.d. x 14 days followed by 900 mg p.o. QD until at least 7 days after a negative test. Eighteen patients (14 sib, four MUD) had 30 episodes of CMV DNA detection treated with oral VGC. Median duration of therapy was 21 days (range 10-21 days). The rate of response was 93% (28/30) as confirmed by a negative assay within 14 days. No significant toxicity was encountered. Two patients failed oral VGC. One case of CMV enteritis was diagnosed in a patient with acute GVHD. Pre-emptive therapy of CMV infection with oral VGC is safe and effective in allogeneic HSCT recip...Continue Reading

References

Nov 1, 1982·Reviews of Infectious Diseases·J D MeyersE D Thomas
Feb 1, 1993·Annals of Internal Medicine·J M GoodrichJ D Meyers
May 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L F VerdonckM R van den Hoek
Dec 30, 1999·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·J SchirmT H The
Feb 7, 2002·Blood·Pierre ReusserUNKNOWN Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Apr 12, 2002·The New England Journal of Medicine·Daniel F MartinUNKNOWN Valganciclovir Study Group
Jul 9, 2002·British Journal of Haematology·Per Ljungman
Nov 1, 2002·Journal of Clinical Microbiology·Adriana WeinbergRoger Giller
Sep 25, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Michael BoeckhJohn Zaia

❮ Previous
Next ❯

Citations

Jun 15, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sharon EladUNKNOWN Viral Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/Internationa
Jan 17, 2009·International Journal of Hematology·Katsuto TakenakaUNKNOWN for Fukuoka Blood and Marrow Transplant Group (FBMTG)
Apr 24, 2010·International Journal of Hematology·Takehiko Mori, Jun Kato
Jul 1, 2008·Bone Marrow Transplantation·P LjungmanUNKNOWN European Conference on Infections in Leukemia
May 1, 2007·The Pediatric Infectious Disease Journal·Luisa GalliMaurizio de Martino
Dec 27, 2011·The Pediatric Infectious Disease Journal·Elise LaunayPhilippe Ovetchkine
Jan 18, 2011·Hematology/oncology Clinics of North America·Per LjungmanMichael Boeckh
Jul 30, 2010·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Hubertus C E BuyckVincent C Emery
May 15, 2010·Infectious Disease Clinics of North America·Per LjungmanMichael Boeckh
Oct 29, 2015·Immunotherapy·Taiga NishihoriMohamed A Kharfan-Dabaja
Oct 11, 2008·Transplant Infectious Disease : an Official Journal of the Transplantation Society·D FocosiM Petrini
May 8, 2013·British Journal of Haematology·Vincent EmeryUNKNOWN UK Virology Network
Apr 27, 2012·British Journal of Haematology·Fiona L DignanUNKNOWN British Society for Blood and Marrow Transplantation
May 20, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Pau MontesinosGuillermo F Sanz
Sep 15, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcie TomblynUNKNOWN Centers for Disease Control and Prevention
Jun 25, 2016·Annals of Hematology·Andrew J UllmannUNKNOWN Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology (AGIHO/DGHO) and the DAG-KBT (Ge
Jun 28, 2016·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Ugur SahinTaner Demirer
Jan 7, 2017·Journal of Pediatric Hematology/oncology·Bethany A WattlesJoshua J Elder
Oct 7, 2017·Future Oncology·Ranjit Kumar ChaudharyVijaya Raj Bhatt
Jan 1, 2007·Intensivmedizin + Notfallmedizin : Organ Der Deutschen Und Der Österreichischen Gesellschaft Für Internistische Intensivmedizin, Der Sektion Neurologie Der DGIM Und Der Sektion Intensivmedizin Im Berufsverband Deutscher Internisten E.V·C E Wrede, E Holler
Sep 11, 2020·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Eisuke SuganumaTsutomu Oh-Ishi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.